Yohei Komaru

Assistant Professor

University of Tokyo Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Yohei Komaru is an Assistant Professor at The University of Tokyo Hospital in Japan. His research focuses on acute kidney injury, interorgan communication, and the implications of immune checkpoint regulators on inflammation and renal health. Recent publications explore topics such as biomarker application in critically ill patients and the impact of treatment timing on kidney-related outcomes.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Kent Doi

University of Tokyo

JAPAN

View details

Teruhiko Yoshida

Lecturer

University of Tokyo

JAPAN

View details

Eirini Kefalogianni

Assistant Professor of Medicine

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Mark Miller

Associate Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Andreas Herrlich

UNITED STATES

View details

Ryota Inokuchi

Associate Professor

University of Tsukuba

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yohei Komaru

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Acute kidney injury triggers hypoxemia by lung intravascular neutrophil retention that reduces capillary blood flow

The immune checkpoint regulator CD40 potentiates myocardial inflammation

Interorgan communication networks in the kidney–lung axis

Solute Clearance Evaluation and Filter Clotting Prediction in Continuous Renal Replacement Therapy

Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study.

Application of urinary biomarkers for diagnosing acute kidney injury in critically ill patients without baseline renal function data.

TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.

Plasma xanthine oxidoreductase is associated with carotid atherosclerosis in stable kidney transplant recipients

Does a slight change in serum creatinine matter in coronavirus disease 2019 (COVID-19) patients?

Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis.

Collaborators (6)

Kent Doi

Teruhiko Yoshida

Eirini Kefalogianni

Mark Miller

Andreas Herrlich

Ryota Inokuchi

Make your next move.